Abstract 4538: Brigatinib induces synergy with PARP inhibitors through dual inhibition of FAK and EphA2 in high-grade serous ovarian carcinoma
Duffield, Julie R., Hou, Xiaonan, McKeon-Makki, Iman K., Huehls, Amelia M., Wilson, Benjamin W., Prasad, Anjali, Wu, Xinyan, Kaufmann, Scott H., Karnitz, Larry M., Weroha, John J., Kanakkanthara, Arun
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article